20 May 2013
Keywords: Ophthotech, Frova, Wet AMD, Ph IIb, Lucentis
Article | 15 June 2012
Privately-held US biotech firm Ophthotech Corp has announced results from the first clinical trial to show statistically significant superior efficacy ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 June 2012
14 June 2012
© 2013 thepharmaletter.com